{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:21Z","timestamp":1790371041199,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1378\/chest.12-0477","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T10:05:22Z","timestamp":1355997922000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Pneumocystis Pneumonia in Patients Treated With Rituximab"],"prefix":"10.1016","volume":"144","author":[{"given":"Isabel","family":"Martin-Garrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1378\/chest.12-0477_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrmicro1621","article-title":"Current insights into the biology and pathogenesis of Pneumocystis pneumonia","volume":"5","author":"Thomas","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10.1378\/chest.12-0477_bib2","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.4049\/jimmunol.176.10.6147","article-title":"B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection","volume":"176","author":"Lund","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1378\/chest.12-0477_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3960\/jslrt.50.159","article-title":"Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab","volume":"50","author":"Kurokawa","year":"2010","journal-title":"J Clin Exp Hematop"},{"issue":"10","key":"10.1378\/chest.12-0477_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3109\/10428194.2010.506569","article-title":"Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy","volume":"51","author":"Hashimoto","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1378\/chest.12-0477_bib5","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/acr.20279","article-title":"Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis","volume":"62","author":"Hugle","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1378\/chest.12-0477_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428191003699860","article-title":"High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone","volume":"51","author":"Kamel","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1378\/chest.12-0477_bib7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3109\/10428190903258780","article-title":"Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma","volume":"50","author":"Katsuya","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1378\/chest.12-0477_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1440-1797.2009.01168.x","article-title":"Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection","volume":"14","author":"Shelton","year":"2009","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1378\/chest.12-0477_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0609.2007.00994.x","article-title":"Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma","volume":"80","author":"Venhuizen","year":"2008","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1378\/chest.12-0477_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.10564","article-title":"Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen","volume":"92","author":"Kolstad","year":"2007","journal-title":"Haematologica"},{"issue":"8","key":"10.1378\/chest.12-0477_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0961203312436855","article-title":"Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy","volume":"21","author":"Tsai","year":"2012","journal-title":"Lupus"},{"issue":"3","key":"10.1378\/chest.12-0477_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1378\/chest.12-0477_bib13","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/annonc\/mdl141","article-title":"High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication","volume":"17","author":"Cabanillas","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1378\/chest.12-0477_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1600-6143.2011.03833.x","article-title":"In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells","volume":"12","author":"Kamburova","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1378\/chest.12-0477_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12185-010-0528-6","article-title":"Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis","volume":"91","author":"Irie","year":"2010","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1378\/chest.12-0477_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.diagmicrobio.2010.10.021","article-title":"Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity","volume":"69","author":"Wilson","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1378\/chest.12-0477_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/art.34584","article-title":"Rituximab for induction and maintenance of refractory granulomatosis and polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arth Rheum"},{"issue":"6","key":"10.1378\/chest.12-0477_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment","volume":"8","author":"Calder\u00f3n","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1378\/chest.12-0477_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1378\/chest.12-0477_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1378\/chest.12-0477_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.171.3.1423","article-title":"Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody","volume":"171","author":"Lund","year":"2003","journal-title":"J Immunol"},{"issue":"25","key":"10.1378\/chest.12-0477_bib22","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1378\/chest.12-0477_bib23","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1378\/chest.12-0477_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.12-0477_bib25","first-page":"496","article-title":"Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity","volume":"91","author":"Brusamolino","year":"2006","journal-title":"Haematologica"},{"issue":"10","key":"10.1378\/chest.12-0477_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1378\/chest.12-0477_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1378\/chest.12-0477_bib28","doi-asserted-by":"crossref","first-page":"L1087","DOI":"10.1152\/ajplung.00441.2005","article-title":"Pneumocystis carinii infection sensitizes lung to radiation-induced injury after syngeneic marrow transplantation: role of CD4+ T cells","volume":"290","author":"Bruckner","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1378\/chest.12-0477_bib29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:38:35Z","timestamp":1757918315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213604754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0012369213604754"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-0477","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969588.793469926","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumocystis Pneumonia in Patients Treated With Rituximab","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-0477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}